A detailed history of Russell Investments Group, Ltd. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 307 shares of HRTX stock, worth $521. This represents 0.0% of its overall portfolio holdings.

Number of Shares
307
Previous 327 6.12%
Holding current value
$521
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.73 - $3.67 $34 - $73
-20 Reduced 6.12%
307 $0
Q2 2024

Aug 08, 2024

BUY
$2.32 - $3.86 $758 - $1,262
327 New
327 $1,000
Q3 2023

Nov 13, 2023

BUY
$0.97 - $1.8 $194 - $360
200 New
200 $0
Q1 2022

May 05, 2022

SELL
$4.63 - $9.94 $19,918 - $42,761
-4,302 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$8.35 - $12.6 $35,921 - $54,205
4,302 New
4,302 $39,000
Q3 2021

Nov 08, 2021

SELL
$10.13 - $15.0 $1.31 Million - $1.94 Million
-129,458 Closed
0 $0
Q2 2021

Aug 04, 2021

SELL
$13.27 - $18.48 $720,335 - $1 Million
-54,283 Reduced 29.54%
129,458 $2.01 Million
Q1 2021

May 10, 2021

BUY
$14.49 - $20.72 $76,289 - $109,090
5,265 Added 2.95%
183,741 $2.98 Million
Q4 2020

Feb 08, 2021

BUY
$14.61 - $22.14 $939,189 - $1.42 Million
64,284 Added 56.29%
178,476 $3.78 Million
Q3 2020

Nov 09, 2020

SELL
$13.67 - $17.77 $113,502 - $147,544
-8,303 Reduced 6.78%
114,192 $1.69 Million
Q2 2020

Aug 05, 2020

BUY
$10.89 - $21.47 $312,553 - $616,210
28,701 Added 30.6%
122,495 $1.8 Million
Q1 2020

May 06, 2020

SELL
$10.23 - $24.56 $115,936 - $278,338
-11,333 Reduced 10.78%
93,794 $1.1 Million
Q4 2019

Jan 29, 2020

BUY
$17.42 - $26.61 $710,683 - $1.09 Million
40,797 Added 63.42%
105,127 $2.47 Million
Q3 2019

Nov 01, 2019

BUY
$16.36 - $21.39 $316,435 - $413,725
19,342 Added 42.99%
64,330 $1.19 Million
Q1 2019

May 13, 2019

BUY
$23.15 - $28.34 $77,251 - $94,570
3,337 Added 8.01%
44,988 $1.1 Million
Q4 2018

Feb 11, 2019

SELL
$22.03 - $32.01 $168,419 - $244,716
-7,645 Reduced 15.51%
41,651 $1.08 Million
Q3 2018

Oct 26, 2018

SELL
$30.0 - $40.85 $48,000 - $65,360
-1,600 Reduced 3.14%
49,296 $1.56 Million
Q2 2018

Aug 08, 2018

BUY
$26.4 - $42.0 $29,462 - $46,872
1,116 Added 2.24%
50,896 $1.98 Million
Q1 2018

May 11, 2018

BUY
$18.43 - $28.8 $917,445 - $1.43 Million
49,780 New
49,780 $1.37 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $202M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.